Managing severe asthma and CRSwNP: Through the lens of Type 2 Inflammation
Managing severe asthma and CRSwNP: Through the lens of Type 2 Inflammation
Opening remarks
Santiago Quirce
Type 2 Inflammation: The common underlying pathway
Enrico Heffler
Panel discussion: What have we learned about Type 2 Inflammation from clinical experience?
Santiago Quirce, Ekkehard Beck, Enrico Heffler, Wytske J. Fokkens
Dupilumab: Targeting Type 2 Inflammation to effectively treat asthma and CRSwNP
Wytske J. Fokkens
Audience Q&A
Santiago Quirce, Ekkehard Beck, Enrico Heffler, Wytske J. Fokkens
Closing remarks
Santiago Quirce